In The News
Effects of ALT‑801, a GLP‑1 and glucagon receptor dual agonist, in a translational mouse model of non‑alcoholic steatohepatitis
April 23, 2022
Source
Scientific Reports
Download PDF 9.7 MB
Potential New Obesity Drug Heads to Phase II Trials
January 31, 2022
Source
BioSpace
